Search Videos and More
News
Baptist Health Recognized as Most Awarded Healthcare System in South Florida based on U.S. News & World Report 2023-2024 Rankings
Baptist Health’s hospitals and institutes are among the very best in America, securing a total of 45 awards.
News
Global Study Holds Promise for Women Diagnosed with Endometrial Cancer
Endometrial cancer, also known as uterine cancer, is the sixth most common cancer among women worldwide and the most common type of gynecologic cancer in the U.S. It affects the endometrium, or lining of the uterus, and can spread to other areas if left untreated.
News
She Defeated Inoperable Pancreatic Cancer Via Most Advanced Radiation Therapy at Baptist Health Miami Cancer Institute
It’s difficult to comprehend a more frightening diagnosis than being told you have advanced and inoperable pancreatic cancer. Connie Harrington, 76, knows exactly the feeling.
News
Research Holds Promising Advances for Brain Tumor Patients
For the nearly 100,000 Americans expected to be diagnosed with a primary brain tumor in 2023, receiving the news will most likely be alarming.
News
Clinical Trial Shows Safety of Ablative Radiotherapy for Inoperable Pancreas Cancer
Researchers at Miami Cancer Institute, a part of Baptist Health, believe they are one step closer to changing the treatment paradigm for patients with inoperable pancreatic cancer.
News
Baptist Health and Florida International University to begin exclusive negotiations on comprehensive alliance
Baptist Health and Florida International University, through its Herbert Wertheim College of Medicine, today announced they have entered into exclusive negotiations to develop a comprehensive alliance, which will drive clinical, research and education advancements for the benefit of the South Florida community.
News
Jean-Marie Stephan, M.D., joins Miami Cancer Institute as Gynecological Surgical Oncologist
Board-certified gynecological surgical oncologist Jean-Marie Stephan, M.D., recently joined Baptist Health Miami Cancer Institute.
News
Radiopharmaceutical PET Agent Helps Physicians Identify Recurrent Brain Metastases
The results of a multi-institutional clinical trial led by Miami Cancer Institute, a part of Baptist Health, could bring a monumental shift in the management of patients with brain metastases. Rupesh Kotecha, M.D., chief of Radiosurgery and director of Central Nervous System Metastasis at the Institute, presented the findings at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on June 2.
News
HER2-Positive Breast Cancer Research: Some Women Can Bypass Radiation
A new study led by Baptist Health Miami Cancer Institute and Lynn Cancer Institute researchers is showing that more women with breast cancer may be able to avoid the toxicities of radiation therapy after mastectomy.
News
Miami Cancer Institute to Present Latest Cancer Research at 2023 ASCO Annual Meeting
Miami Cancer Institute, part of Baptist Health South Florida, today announced its oral and poster presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2-6, at McCormick Place in Chicago, Illinois.
News
Cracking Glioblastoma’s Deadly Code: Research Focused on Improving Diagnosis and Genomics to Revolutionize Care
Even with growing awareness of the devastating effects of glioblastoma, the most common and aggressive form of brain cancer, treatment options remain limited and patients typically survive just 15-18 months beyond diagnosis. Researchers at the Miami Cancer Institute and Miami Neuroscience Institute, part of Baptist Health South Florida, are focusing their efforts to advance understanding of the disease and improve diagnostic, prognostic, and therapeutic outcomes.
News
Lutetium-177 (177Lu) - PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Updated National Society Guidelines
The most recent American Society of Clinical Oncology (ASCO) guidelines for the management of metastatic castration-resistant prostate cancer (mCRPC) was published in 2014.